Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy

Solid Tumors After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study

(2013) Chunkit Fung et al.   JOURNAL OF CLINICAL ONCOLOGY

Bilateral testicular germ cell tumours: a systematic review

(2012) Stenio de Cassio Zequi et al.   BJU INTERNATIONAL

Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

(2012) Hege S. Haugnes et al.   JOURNAL OF CLINICAL ONCOLOGY

Secondary malignancies among nonseminomatous germ cell tumor cancer survivors

(2011) Karim Chamie et al.   CANCER

Sequelae of Treatment in Long-term Survivors of Testis Cancer

(2011) Robert Abouassaly et al.   EUROPEAN UROLOGY

EAU Guidelines on Testicular Cancer: 2011 Update

(2011) Peter Albers et al.   EUROPEAN UROLOGY

Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study

(2010) Hege S. Haugnes et al.   JOURNAL OF CLINICAL ONCOLOGY

Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy

(2009) C. Kollmannsberger et al.   ANNALS OF ONCOLOGY

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

(2009) Torgrim Tandstad et al.   JOURNAL OF CLINICAL ONCOLOGY

Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors

(2009) M. Brydoy et al.   JNCI-Journal of the National Cancer Institute

Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): A risk adapted protocol of the Hellenic Cooperative Oncology Group

(2009) Aristotelis Bamias et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

High-risk clinical stage I nonseminomatous germ cell tumors: the case for chemotherapy

(2009) Dirk H. Westermann et al.   WORLD JOURNAL OF UROLOGY

Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group

(2008) Peter Albers et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Followup Results of 1 Cycle of Adjuvant Bleomycin, Etoposide and Cisplatin Chemotherapy for High Risk Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis

(2007) Dirk H. Westermann et al.   JOURNAL OF UROLOGY